Multi‐resonance thermally activated delayed fluorescence (MR‐TADF) has established a new approach for narrowband blue organic light emitting diodes (OLEDs), yet effectively suppressing intermolecular interactions especially at high doping concentrations while preserving the intrinsic narrowband emission remains a formidable challenge. Herein, a novel designing paradigm is proposed for achieving anti‐quenching narrowband emission in MR‐TADF molecules by embedding the indeno[2,1‐b]carbazole unit into the polycyclic aromatic hydrocarbon skeleton. The proof‐of‐concept emitter DT‐BON1 reveals a favorable twist angle of 31.8°, manifesting formation of helical architecture within MR core. As a result, the emission peaks and full width at half maximum show virtually no variation with changing doping concentration from 1 wt% to 20 wt%. Moreover, the photoluminance quantum yields exceed 90% even at 20 wt% doping concentration endowed by the outstanding anti‐quenching characteristics. The DT‐BON1 based OLEDs can achieve maximum external quantum efficiency (EQE max ) of exceeding 30%. Especially, the alleviated exciton quenching effects can be firmly demonstrated by marginally decreased EQE max values, attaining 29.2% in 10 wt%‐based OLEDs and 27.3% even in heavily doped devices (20 wt%), which is at a record high for MR‐TADF with blue emission at such high doping concentration.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: